AI Radiology Tool Market

AI Radiology Tool Market Outlook from 2024 to 2034

Future Market Insights opines in its latest report that the global AI radiology tool market yields a current valuation of USD 269.5 million in 2024. As the global healthcare sector experiences major technological breakthroughs, the scope for AI radiology tools is only set to rise.

Going forward, the market for AI radiology tools is slated to proliferate at a staggering 14.2% CAGR from 2024 to 2034. Given the lucrativeness of AI penetration, this market is en route to attaining a valuation of USD 1,018.7 million.

Attributes	Key Insights
Estimated Market Size in 2024	USD 269.5 million
Projected Market Value in 2034	USD 1,018.7 million
Value-based CAGR from 2024 to 2034	14.2%

Key Market Trends and Highlights

• The rising prevalence of chronic diseases can be arrested with the help of radiology tools. Moreover, predictive analysis can produce probabilities of the same disease, and a specific pattern can be studied. This is a key market trend in the subject market.
• The proactive medical approach is another key market trend driving the subject market. Medical professionals are keen to diagnose and analyze the patient’s health more proactively. As a result, the speed of diagnostics tests must be increased, which can be achieved by integrating AI tools. Hence, this is another critical market trend.
• Governments are fostering the use and implementation of AI tools. To achieve this, they validate AI radiology tools through regulatory approvals. It is another key trend uplifting the market.

Demand Analysis of AI Radiology Tool Market from 2019 to 2023 vs. Outlook from 2024 to 2034

The historical CAGR of 13.5% elevated the AI radiology tool market from USD 143.3 million to USD 237.5 million from 2019 to 2023. This market advancement is attributed to various drivers and demand generators.

The primary demand generator can be attributed to the increasing awareness in the subject market. The importance and the reach of AI in the radiology sector were emphasized, which surged the demand for relevant apparatus and tools. As a result, this has been a prime demanding factor in the historical period.

Apart from this, the historical period was governed by the pandemic. The rising cases of patients required accelerated testing and diagnostics, which was possible with the use of AI radiology tools. Consequently, it was another demand generator in the market.

Historical CAGR from 2019 to 2023	13.5%
Forecast CAGR from 2024 to 2034	14.2%

The forecasted period focuses on technological development. Due to the rapid growth in the relevant infrastructure, integration of AI into radiology systems has become easier. Hence, it will likely create more demand in different medical verticals.

Government initiatives and incentivization drive the subject market. Monetary investments in building technological infrastructure help the market become more affordable for small-scale businesses. Thus, lucrative growth prospects are created in the market, generating more demand for AI radiology tools.

Market Drivers

• The growing demand for accurate and precise diagnostics results drives the AI radiology tool market. With the help of technological integration, outcomes of even minute discrepancies can be identified, improving the medication. Hence, this is a primary market driver.
• The growth of the technological infrastructure further builds prospective growth chances for the subject market. This is because acquiring bleeding-edge technology will become easier and more affordable, resulting in market advancement.
• Governmental support is another vital market driver that assists growth. For example, the Chinese government is incentivizing the healthcare sector. It is also investing heavily to support technological integration. So, this drives the subject market.
• The workload management of radiologists has been a key concern in many countries. To release some pressure, AI is integrated into radiology tools to increase accuracy and reduce error percentage. Hence, this drives the subject market.

Market Challenges

• Integrating AI radiology tools into healthcare might be burdensome for underdeveloped economies. Consequently, the market might not find a niche in such countries. This is a key market challenge.
• Data privacy might be another key concern. Radiology tools will fetch data for predictive analysis, which might be theft or misused, creating a serious threat.

Country-wise Analysis

North America leads the global AI radiology tool market. The development of the technological infrastructure assists the growth of the market in the region. Additionally, government initiatives fuel the advancement of the market.

The Asia-Pacific region supports market growth by developing the medical and healthcare sectors. Emerging markets in the area contribute significantly to the development of the subject industry.

Developed European countries provide a better platform for radiology practices, helping practitioners to integrate cutting-edge technology into their practice.

Forecast CAGRs from 2024 to 2034

Countries	Forecasted CAGR
The United States of America	5.3%
Germany	3.7%
China	7.1%
Japan	3%
Australia & New Zealand	5.1%

Electronic Health Records Integrate AI in the United States of America, Advancing the AI radiology tool market

The United States of America estimates the market advancement at a CAGR of 5.3% through 2034, leading North America. To develop and foster patient management, AI radiology tools are integrated into electronic health records.

This delivers predictive analysis to the medical professionals, ensuring a seamless workflow. Further, workflow optimization can be ensured, enhancing test results' accuracy. Hence, this is the primary market driver for the market.

Digital Health Innovation in Germany Fosters the Market Growth

Germany estimates the market progress at a sluggish CAGR of 3.7%, primarily due to the digitization of healthcare systems. The German government is emphasizing digitization. It has implemented the Digital Healthcare Act (DVG) to achieve this.

Under this law, doctors are abide to prescribe digital health applications (DiGAs). These include AI-powered tools. Also, these tools are reimbursed by health insurance. Such initiatives can be seen to fuel the demand for the generation of AI radiology tools. Therefore, this is a critical driver for the subject market.

Investments in the Healthcare Sector Uplift the Chinese AI Radiology Tool Market

The Chinese government has been investing heavily in AI healthcare. According to McKinsey and Company, approximately USD 600 billion is to be financed by the government in the industry. This investment will likely boost innovation in AI tools, ensuring increased precision in applying tools.

The increased tool efficiency delivers optimum results for the radiology field, optimizing the healthcare sector. Therefore, this is the primary market driver for the Chinese AI radiology tool market. The market will progress at the highest CAGR of 7.1% through 2034.

Japan Emphasizes the Enhancement of Diagnostics Systems for Aged People

The Japanese demographics attributed to the aged population greatly burden healthcare systems. Due to this, the existing resources in the healthcare sector are strained.

The issue can be resolved by integrating AI with diagnostics systems to leverage faster and more accurate test results. Moreover, the efficiency of these tools will surge their demand in the entire Japanese healthcare sector, driving the subject market. Hence, this forecasts the market Japanese market advancement at a CAGR of 3%.

Australia and New Zealand Create Lucrative Prospects through Cross-Border Healthcare Initiatives

Australia and New Zealand estimate stable market progress at a CAGR of 5.1% through 2034. Governments of these countries are keen on the standardization process of AI radiology tools.

This initiative enables healthcare systems to access remote areas, facilitating accurate disease detection. To achieve this, cross-border healthcare agreements are signed between two countries, leveraging the market growth. Therefore, this is a primary market driver.

Category-wise Insights

Category	Diagnostic Radiology
Market Share in 2024	55%
Market Segment Drivers	The ability of instruments to detect even the slightest abnormality increases the popularity of AI-powered tools. Error reduction in diagnostic radiology fuels the demand for AI tools, which drives the market segment.

Category	Diagnostic Centers
Market Share in 2024	46%
Market Segment Drivers	The ability of AI radiology tools to produce highly tailored medical treatments enhances their popularity at diagnostic centers. Small-scale diagnostic centers in remote villages can also prevail in tailored patient treatment, which surges their demand.

Competitive Landscape

The global AI radiology tool market is saturated due to excessive competition. It clutters the market, hindering the growth prospects for the new entrants. So, a prospective business needs to emphasize market penetration using product innovation to provide more market space to the industry.

Existing competitors are keen to use key market expansion strategies. These are strategic collaborations, branding, investments, mergers and acquisitions, and many others.

Key Market Developments

• In February 2023, GE Healthcare acquired Caption Health. The strategic initiative was taken to support a USD 3 billion ultrasound business with the help of AI-enabled image guidance to ultrasound device portfolios.
• In May 2023, Brainomix Limited extended new facilities at its headquarters in the United Kingdom. This strategic move has allowed the organization to expand its portfolio beyond stroke.
• In July 2023, RapidAI gained USD 75 million in funding from Vista Credit Partners, a subsidiary of Vista Equity Partners. They are the strategic financers of the organization. The fundamental goal of this funding was to elevate platform innovation standards.

Key Coverage of AI Radiology Tool Market Report

• Key demand-side and supply-side trends in the market.
• Emerging prospect regions providing growth opportunities.
• Key market developments made by key market players.
• Market analysis using theoretical frameworks like PESTLE, SWOT, and Porter’s five-force analysis.
• Market dynamics and forces affecting the market growth.

Report Scope

Attributes	Details
Estimated Market Size in 2024	USD 269.5 million
Projected Market Valuation in 2034	USD 1,018.7 million
Value-based CAGR 2024 to 2034	14.2%
Forecast Period	2024 to 2034
Historical Data Available for	2019 to 2023
Market Analysis	Value in USD million
Key Regions Covered	North America; Latin America; Western Europe; Eastern Europe; South Asia and Pacific; East Asia; The Middle East and Africa
Key Market Segments Covered	Type, End User, Region
Key Countries Profiled	The United States, Canada, Brazil, Mexico, Germany, The United Kingdom, France, Spain, Italy, Poland, Russia, Czech Republic, Romania, India, Bangladesh, Australia, New Zealand, China, Japan, South Korea, GCC Countries, South Africa, Israel
Key Companies Profiled	IBM; Bay Labs; Resonance Health; Zebra Medical Vision; Samsung Electronics; Arterys; Koninklijke Philips; Nuance Communications; Siemens Healthineers AG; OrCam

Table of Content

• 1. Executive Summary
• 2. Market Overview
• 3. Market Background
• 4. Global Market Analysis 2019 to 2023 and Forecast, 2024 to 2034
• 5. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Type
  • 5.1. Diagnostic Radiology
  • 5.2. Interventional Radiology
• 6. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By End User
  • 6.1. Clinics
  • 6.2. Hospitals
  • 6.3. Diagnostic Centres
  • 6.4. Others
• 7. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Region
  • 7.1. North America
  • 7.2. Latin America
  • 7.3. Western Europe
  • 7.4. Eastern Europe
  • 7.5. South Asia and Pacific
  • 7.6. East Asia
  • 7.7. Middle East and Africa
• 8. North America Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
• 9. Latin America Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
• 10. Western Europe Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
• 11. Eastern Europe Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
• 12. South Asia and Pacific Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
• 13. East Asia Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
• 14. Middle East and Africa Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
• 15. Key Countries Market Analysis
• 16. Market Structure Analysis
• 17. Competition Analysis
  • 17.1. IBM
  • 17.2. Bay Labs
  • 17.3. Resonance Health
  • 17.4. Zebra Medical Vision
  • 17.5. Samsung Electronics
  • 17.6. Arterys
  • 17.7. Koninklijke Philips
  • 17.8. Nuance Communications
  • 17.9. Siemens Healthineers AG
  • 17.10. OrCam
• 18. Assumptions & Acronyms Used
• 19. Research Methodology